Acta Dermato-Venerelogica Issue No 7, 2017 97-7CompleteContent | Page 12
802
INVESTIGATIVE REPORT
Variation in Staphylococcus aureus Colonization in Relation to
Disease Severity in Adults with Atopic Dermatitis during a Five-
month Follow-up
Mikael ALSTERHOLM 1 , Louise STRÖMBECK 1 , Annika LJUNG 2 , Nahid KARAMI 2 , Johan WIDJESTAM 2 , Martin GILLSTEDT 1 ,
Christina ÅHREN 2 and Jan FAERGEMANN 1
1
Department of Dermatology and Venereology, Sahlgrenska University Hospital, and 2 Department of Infectious Diseases, Institute of
Biomedicine, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
The aim of this study was to monitor Staphylococcus
aureus colonization and disease severity in adults with
atopic dermatitis (AD) during 5 months. Twenty-one
patients attended 3 visits each for severity SCORing of
Atopic Dermatitis (SCORAD) assessment, quantitative
cultures from the skin and conventional cultures from
the anterior nares, tonsils and perineum. S. aureus iso-
lates were typed for strain identity with pulsed-field
gel electrophoresis (PFGE). Seventy-one percent of
patients were colonized with S. aureus on lesional skin
at least once. Density (colony-forming units (CFU)/
cm 2 ) was higher on lesional skin than on non-lesional
skin (p < 0.05). Density on lesional skin and number
of colonized body sites were positively correlated with
SCORAD (p = 0.0003 and p = 0.007, respectively). Per-
sistent carriers of the same strain on lesional skin had
higher mean SCORAD index than intermittent/non-
carriers (36.3 and 17.1, respectively, p = 0.002). The
results show a temporal correlation between several
aspects of S. aureus colonization and disease severity
in AD raising the question of the importance of this in
pathogenesis and treatment.
Key words: atopic dermatitis; S. aureus; SCORAD; PFGE.
Accepted Apr 4, 2017; Epub ahead of print Apr 4, 2017
Acta Derm Venereol 2017; 97: 802–807.
Corr: Mikael Alsterholm, Department of Dermatology and Venereology,
Sahlgrenska University Hospital, Gröna Stråket 16, SE-413 45 Göteborg,
Sweden. E-mail: [email protected]
S
taphylococcus aureus is a gram-positive bacteria that
can act as a human commensal on the skin as well as
a causative agent in several types of skin and soft tissue
infections. The carriage pattern of S. aureus in healthy
subjects has been studied extensively (1). The nasal cavity,
skin, perineum and pharynx can all carry S. aureus, with
the anterior nares being the most common site of carriage.
Carriage rate on the skin ranges from 5% to 30% depen-
ding on body site and whether the individual is a persistent
nasal carrier. In contrast, lesional skin of patients with
atopic dermatitis (AD) is reported to be colonized with
S. aureus in 70% of cases (2). Flare-ups of AD are often
associated with S. aureus super-infection, and one treat-
ment strategy is the use of topical or oral antimicrobials
(3). While there is a strong link between acute S. aureus
infection of the skin and increase in disease activity, the
doi: 10.2340/00015555-2667
Acta Derm Venereol 2017; 97: 802–807
role of colonization in the pathogenesis and maintenance
of AD remains unclear.
A currently favoured theory in AD pathogenesis is the
“outside-in” hypothesis, whereby an impaired epidermal
barrier, allowing penetration of environmental substances
into the skin, is described as the starting point in an early
march towards atopy (4). As a consequence there is sensi-
tization to microbial products and allergens, which in turn
triggers an immune dysregulation followed by inflamma-
tion of the skin. In 1990, Williams et al. (5) demonstrated
a positive correlation between S. aureus density on lesional
skin and the severity of AD, later confirmed by numerous
other investigators (6). In recent years, several studies have
demonstrated a higher disease activity in AD associated with
the presence of S. aureus and sensitization to staphylococcal
toxins (7–12). Lomholt et al. (13) reported that a change
from one colonizing strain of S. aureus to another was as-
sociated with increased disease activity in children with AD.
In view of this, it is somewhat surprising that there is
little, and also conflicting, data to support the efficacy of
anti-staphylococcal interventions in patients, primaril y
children, with clinically non-infected AD (14–16). The
failure to demonstrate convincing clinical benefit could be
due to a lack of high-quality randomized controlled trials,
as concluded in a Cochrane review on this topic (17). An-
other explanation could lie in the selection of patients for
interventional studies. Presumably, the pattern of S. aureus
colonization varies between patients. It could be suggested
that only those with persistent and high-density colonization
are likely to benefit from anti-staphylococcal interventions.
Variation in S. aureus colonization over time in rela-
tion to severity of AD has, to our knowledge, rarely been
described in adult patients. Therefore, we investigated S.
aureus carriage in adults with AD at repeated visits during
a 5-month follow-up period to investigate whether any
temporal shifts in S. aureus carriage occurred and if this
could be related to disease severity measured with the
SCORAD index.
METHODS
Patients
The study was conducted at the Department of Dermatology and
Venereology, Sahlgrenska University Hospital and at the Depart-
ment of Infectious Diseases, Institute of Biomedicine, The Sahl-
grenska Academy at the University of Gothenburg in 2010–2012.
This is an open access article under the CC BY-NC license. www.medicaljournals.se/acta
Journal Compilation © 2017 Acta Dermato-Venereologica.